In mice, pharmacological or genetic inactivation of SIRT2 increases β cell proliferation in the presence of elevated glucose levels, both ex vivo and in preclinical models of diabetes, with no effect on β cell proliferation or pancreatic insulin+ area in euglycemic conditions. The gene discussed is SIRT2; the disease is diabetes mellitus.